More Articles

Endo to buy specialty generic drugmaker Boca Pharmacal Pharma News | Posted 06/09/2013

Specialty pharmaceutical maker Endo Health Solutions (Endo) announced on 28 August 2013 that its generics subsidiary, Qualitest, has agreed to buy specialty generic drugmaker Boca Pharmacal (Boca)...

Baxter and Coherus to collaborate on biosimilars Biosimilars/News | Posted 06/09/2013

Baxter International (Baxter) has made another agreement for biosimilars, this time with fledgling biotech company Coherus Biosciences (Coherus).

Mylan and Par pass FDA scrutiny on Wellbutrin generics Generics/News | Posted 06/09/2013

Mylan and Par Pharmaceutical (Par) announced on 20 and 22 August 2013, respectively, that they have passed FDA scrutiny of their generics of antidepressant Wellbutrin XL (bupropion).

Biosimilar manufacturers fail to compete in Italy Biosimilars/Research | Posted 30/08/2013

In the current global economic crisis, significant savings on healthcare spending should be made as a result of increased competition between manufacturers of off-patent biologicals or biosimilars....

Strategies used by sickness funds to increase generics prescribing in Austria Generics/Research | Posted 30/08/2013

In 2010, a survey of Austrian sickness funds was undertaken to evaluate how Austrian doctors, patients and pharmacists are encouraged to enhance the rational use of medicines, and increase use of g...

Amgen and Pfizer seek deal with Russian non-originator biologicals firm Pharma News | Posted 30/08/2013

Russian biotechnology company Biocad is reported to be attracting offers from US-based Pfizer and biotechnology giant Amgen.

India to make prescribing of generics compulsory Policies & Legislation | Posted 30/08/2013

A parliamentary panel is proposing that the Indian Government should bring in legislation that would make it compulsory for doctors to prescribe only low cost generic drugs.

Generics manufacturers increase investment in injectables Pharma News | Posted 30/08/2013

Generic drugmaker Zydus Cadila, the fifth largest pharmaceutical company in India, is set to invest about US$15.8 million in building an FDA-approved injectables-manufacturing plant. The news in Au...